Biocon (BIOCON) Share Price Fall Streak: Stock Slips Again
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
Biocon Share Price Fall Streak is visible in the latest trade, with the stock at Rs 351.75 after a 2.43% decline and a cumulative 4.57% fall across the second straight session. According to latest Univest figures, the pattern is confirmed, but no company-specific catalyst is established. For readers following Biocon Share Price Fall Streak, the move matters because it combines back-to-back lower sessions with a sizeable market capitalisation and a valuation that still needs to be read in context.
The wider read on Biocon Share Price Fall Streak is that a run of consecutive lower sessions says more than a single-day dip. It changes how Biocon Share Price Fall Streak is interpreted because the stock has moved away from its recent base over two sessions rather than one. According to Univest data, the company is still a Large Cap with a market capitalisation of Rs 60,070.53 crore, so the move remains important for investors tracking Biocon Share Price Fall Streak as a large-company price event.
Biocon (BIOCON) Share Price Fall Streak: Consecutive Decline Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 351.75 |
| Previous Close | Rs 360.5 |
| Today's Move | -Rs 8.75 (-2.43%) |
| Open | Rs 360.05 |
| High | Rs 361.05 |
| Low | Rs 350.8 |
| Market Capitalisation | Rs 60,070.53 crore |
Biocon Share Price Fall Streak opened with the latest traded price at Rs 351.75 versus the previous close of Rs 360.50, a decline of Rs 8.75 or 2.43%. The stock opened at Rs 360.05, touched a high of Rs 361.05 and a low of Rs 350.80, which places the latest traded price near the lower end of the day’s range. That range matters for Biocon Share Price Fall Streak because it shows the stock stayed weak after the open rather than recovering back toward the session high.
According to latest Univest figures, the market capitalisation stood at Rs 60,070.53 crore and the market-cap category is Large Cap. For Biocon Share Price Fall Streak, the important point is not just the single-session move but the fact that the decline adds to the two-session pattern. The latest price is also below the streak start base price of Rs 368.60, which leaves the cumulative move at -4.57% across the run. That keeps Biocon Share Price Fall Streak firmly in focus as a price event that still needs fundamental context.
What the Consecutive Declines Show
Biocon Share Price Fall Streak is now a second straight session, and that sequence is the key market fact. The first lower session set the base, and the latest decline extends the move to -4.57% from Rs 368.60. For readers, the difference is straightforward: one lower session can be an isolated slip, while two consecutive lower sessions create a visible pattern in Biocon Share Price Fall Streak.
The latest session also moved within a narrow band around the open, which keeps attention on how the stock has behaved across the streak rather than on one intraday print. According to Univest data, Biocon Share Price Fall Streak now reflects repeated downside sessions without any verified company-specific reason attached to the move. That makes the streak itself the main story until fresh fundamentals or company updates change the picture.
Biocon (BIOCON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 60,070.53 crore |
| P/E Ratio | 118.62x |
| P/B Ratio | 1.73x |
| ROE | 1.35% |
| ROCE | 3.26% |
| EPS | Rs 3.04 |
| Book Value Per Share | Rs 208.53 |
| Dividend Yield | 0.14% |
Biocon (BIOCON) fundamental metrics show P/E 118.62x, P/B 1.73x, ROE 1.35%, ROCE 3.26%. Read together, these ratios describe the company’s position rather than a recommendation.
Biocon has a market capitalisation of Rs 60,070.53 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 118.62x, P/B at 1.73x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 1.35% and ROCE of 3.26%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.04, book value per share of Rs 208.53, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 118.62x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 1.73x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 1.35% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 3.26% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 60,070.53 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Biocon (BIOCON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Biocon (BIOCON) has a P/E ratio of 118.62x, which is above the benchmark median of 31.87x, a difference of +272.2%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Biocon (BIOCON) has a ROE of 1.35%, which is below the benchmark median of 11.61%, a difference of -88.37%. Biocon (BIOCON) has a ROCE of 3.26%, which is below the benchmark median of 13.46%, a difference of -75.78%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,81,739.76 | 82.14 | 19.96 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
Biocon (BIOCON) has a P/E ratio of 118.62x compared with the displayed peer median of 82.14x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 1.35% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 3.26% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Biocon (BIOCON) has a market capitalisation of Rs 60,070.53 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Biocon
- Biocon Share Price Fall Streak is in a second straight session, which makes the decline a pattern rather than a one-off slip.
- The latest traded price of Rs 351.75 remains below the streak start base price of Rs 368.60, keeping the cumulative move at -4.57%.
- Biocon Share Price Fall Streak is being read against a P/E of 118.62 and a P/B of 1.73, both of which frame valuation after the drop.
- The company’s ROE of 1.35% and ROCE of 3.26% remain well below the healthcare industry benchmark figures in the latest Univest data.
- Biocon Share Price Fall Streak is important because its Rs 60,070.53 crore market capitalisation places it in the Large Cap category.
About Biocon
Biocon operates in Healthcare and the Pharmaceuticals & Drugs industry. For readers tracking Biocon Share Price Fall Streak, the business context matters because the stock belongs to a large listed pharma company with a market capitalisation of Rs 60,070.53 crore. The company is assessed here through the numbers that frame Biocon Share Price Fall Streak: earnings per share, book value, return ratios and valuation multiples. That gives the price move a corporate context without turning it into a separate company profile.
Track Biocon Share Price on Univest
Use Biocon (BIOCON) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Biocon Share Price Fall Streak, live share price movement, valuation ratios, 52-week levels and market insights on Univest. The same page also helps compare the stock with sector benchmarks and peers in one place. For users watching Biocon Share Price Fall Streak, that makes it easier to follow price action and the key fundamentals together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Biocon Share Price falling today?
Ans. Biocon Share Price Fall Streak is visible in the latest trade, but the data confirms the decline without establishing a company-specific cause. The stock was at Rs 351.75, down 2.43% from the previous close.
What is Biocon Share Price today?
Ans. Biocon Share Price Fall Streak shows the latest traded price at Rs 351.75. It was below the previous close of Rs 360.50 and also below the streak start base price of Rs 368.60.
How much has Biocon Share Price fallen in the streak?
Ans. Biocon Share Price Fall Streak has declined 4.57% cumulatively across the second straight session. The latest session alone showed a 2.43% drop, which extended the lower-price pattern. The previous close was Rs 360.5.
Is Biocon a Large Cap stock?
Ans. Yes. Biocon Share Price Fall Streak is happening in a Large Cap company with a market capitalisation of Rs 60,070.53 crore. That size makes the decline relevant for broader healthcare tracking.
What does Biocon P/E ratio show after the fall?
Ans. Biocon Share Price Fall Streak leaves the stock at a P/E of 118.62. Because earnings have not changed across the streak, the multiple reflects the lower price against the same earnings base.
How does Biocon compare with healthcare peers?
Ans. Biocon Share Price Fall Streak shows a higher P/E than peers such as Cipla, Zydus Lifesciences, Dr. Reddy's Laboratories and Aurobindo Pharma. Its ROE and ROCE are also below the peer figures shown.
What are Biocon 's ROE and ROCE?
Ans. Biocon Share Price Fall Streak is accompanied by ROE of 1.35% and ROCE of 3.26%. Those figures sit below the healthcare benchmark medians and below the peer set in the comparison section.
What is the book value and EPS for Biocon ?
Ans. Biocon Share Price Fall Streak can be read alongside EPS of Rs 3.04 and book value of Rs 208.53. EPS reflects earnings per share, while book value shows the accounting net worth behind each share.
How can investors track Biocon Share Price on Univest?
Ans. Biocon Share Price Fall Streak can be followed on Univest with live price movement, valuation ratios, 52-week levels and market insights. That gives readers a single place to monitor the stock and its benchmarks.
